换一批
换一批Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
第一单位：
Centre for Vision Sciences, The Queen's University of Belfast and The Royal Victoria Hospital, Belfast, United Kingdom.
作者：
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);适体, 核苷(Aptamers, Nucleotide);脉络膜新生血管化(Choroidal Neovascularization);双盲法(Double-Blind Method);女(雌)性(Female);荧光素血管造影术(Fluorescein Angiography);人类(Humans);吲哚花青绿(Indocyanine Green);注射(Injections);黄斑变性(Macular Degeneration);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies);治疗结果(Treatment Outcome);血管内皮生长因子A(Vascular Endothelial Growth Factor A);视敏度(Visual Acuity);玻璃体(Vitreous Body)
DOI
10.1016/j.ophtha.2006.02.064
PMID
16828500
发布时间
2022-03-31
- 浏览28
Ophthalmology
1508.e1-25页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
